BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21913655)

  • 1. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
    Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.
    Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
    Biochemistry; 1995 Mar; 34(9):2925-36. PubMed ID: 7534477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
    Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
    Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the CMP-Sialic Acid Donor Specificity of Two Human β-d-Galactoside Sialyltransferases (ST3Gal I and ST6Gal I) Selectively Acting on O- and N-Glycosylproteins.
    Noel M; Gilormini PA; Cogez V; Yamakawa N; Vicogne D; Lion C; Biot C; Guérardel Y; Harduin-Lepers A
    Chembiochem; 2017 Jul; 18(13):1251-1259. PubMed ID: 28395125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of porcine liver gal beta (1 leads to 3)galnac-r alpha(2 leads to 3) sialyltransferase sialylation of mucin-type acceptors and ganglioside GM1 in vitro.
    Bergh ML; Hooghwinkel GJ; Van den Eijnden DH
    Biochim Biophys Acta; 1981 Aug; 660(2):161-9. PubMed ID: 7284398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
    Hamamoto T; Kurosawa N; Lee YC; Tsuji S
    Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids.
    Okajima T; Fukumoto S; Miyazaki H; Ishida H; Kiso M; Furukawa K; Urano T; Furukawa K
    J Biol Chem; 1999 Apr; 274(17):11479-86. PubMed ID: 10206952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
    Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
    J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of galactose alpha2,3-sialyltransferase: Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids.
    Lehmann F; Kelm S; Dietz F; von Itzstein M; Tiralongo J
    Glycoconj J; 2008 May; 25(4):323-34. PubMed ID: 17973185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
    Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
    Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
    Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
    Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
    Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
    J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
    Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
    J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polypeptide part of human chorionic gonadotrophin affects the kinetics of alpha 6-sialylation of its N-linked glycans but does not alter the branch specificity of CMP-NeuAc:Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase.
    Nemansky M; Edzes HT; Wijnands RA; Van den Eijnden DH
    Glycobiology; 1992 Apr; 2(2):109-17. PubMed ID: 1606356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of the major brain gangliosides GD1a and GT1b.
    Sturgill ER; Aoki K; Lopez PH; Colacurcio D; Vajn K; Lorenzini I; Majić S; Yang WH; Heffer M; Tiemeyer M; Marth JD; Schnaar RL
    Glycobiology; 2012 Oct; 22(10):1289-301. PubMed ID: 22735313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases.
    Uslupehlivan M; Şener E; İzzetoğlu S
    Carbohydr Res; 2019 Dec; 486():107823. PubMed ID: 31557542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel viral alpha2,3-sialyltransferase (v-ST3Gal I): transfer of sialic acid to fucosylated acceptors.
    Sujino K; Jackson RJ; Chan NW; Tsuji S; Palcic MM
    Glycobiology; 2000 Mar; 10(3):313-20. PubMed ID: 10704530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lung adenocarcinoma alpha1,3/4-L-fucosyltransferase displays two molecular forms, high substrate affinity for clustered sialyl LacNAc type 1 units as well as mucin core 2 sialyl LacNAc type 2 unit and novel alpha1,2-L-fucosylating activity.
    Chandrasekaran EV; Chawda R; Rhodes JM; Xia J; Piskorz C; Matta KL
    Glycobiology; 2001 May; 11(5):353-63. PubMed ID: 11425796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.